載入...
Integration of Bioinformatics Resources Reveals the Therapeutic Benefits of Gemcitabine and Cell Cycle Intervention in SMAD4-Deleted Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is the most common and aggressive type of pancreatic cancer. The five-year survival rate of PDAC is very low (less than 8%), which is associated with the late diagnosis, high metastatic potential, and resistance to therapeutic agents. The identification of bet...
Na minha lista:
| 發表在: | Genes (Basel) |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6827004/ https://ncbi.nlm.nih.gov/pubmed/31569425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/genes10100766 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|